Literature DB >> 19322812

1H HR-MAS and genomic analysis of human tumor biopsies discriminate between high and low grade astrocytomas.

Valeria Righi1, Jose M Roda, José Paz, Adele Mucci, Vitaliano Tugnoli, Gemma Rodriguez-Tarduchy, Laura Barrios, Luisa Schenetti, Sebastián Cerdán, María L García-Martín.   

Abstract

We investigate the profile of choline metabolites and the expression of the genes of the Kennedy pathway in biopsies of human gliomas (n = 23) using (1)H High Resolution Magic Angle Spinning (HR-MAS, 11.7 Tesla, 277 K, 4000 Hz) and individual genetic assays. (1)H HR-MAS spectra allowed the resolution and relative quantification by the LCModel of the resonances from choline (Cho), phosphocholine (PC) and glycerophosphorylcholine (GPC), the three main components of the combined tCho peak observed in gliomas by in vivo (1)H NMR spectroscopy. All glioma biopsies depicted a prominent tCho peak. However, the relative contributions of Cho, PC, and GPC to tCho were different for low and high grade gliomas. Whereas GPC is the main component in low grade gliomas, the high grade gliomas show a dominant contribution of PC. This circumstance allowed the discrimination of high and low grade gliomas by (1)H HR-MAS, a result that could not be obtained using the tCho/Cr ratio commonly used by in vivo (1)H NMR spectroscopy. The expression of the genes involved in choline metabolism has been investigated in the same biopsies. High grade gliomas depict an upregulation of the beta gene of choline kinase and phospholipase C, as well as a downregulation of the cytidyltransferase B gene, the balance of these being consistent with the accumulation of PC. In the low grade gliomas, phospholipase A(1) and lysophospholipase are upregulated and phospholipase D is downregulated, supporting the accumulation of GPC. The present findings offer a promising procedure that will potentially help to accurately grade glioma tumors using (1)H HR-MAS, providing in addition the genetic background for the alterations of choline metabolism observed in high and low grade gliomas. Copyright (c) 2009 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19322812     DOI: 10.1002/nbm.1377

Source DB:  PubMed          Journal:  NMR Biomed        ISSN: 0952-3480            Impact factor:   4.044


  33 in total

1.  Ex vivo MR spectroscopic measure differentiates tumor from treatment effects in GBM.

Authors:  Radhika Srinivasan; Joanna J Phillips; Scott R Vandenberg; Mei-Yin C Polley; Gabriela Bourne; Alvin Au; Andrea Pirzkall; Soonmee Cha; Susan M Chang; Sarah J Nelson
Journal:  Neuro Oncol       Date:  2010-07-20       Impact factor: 12.300

2.  Short-term temperature effect on the HRMAS spectra of human brain tumor biopsies and their pattern recognition analysis.

Authors:  Daniel Valverde-Saubí; Ana Paula Candiota; Maria Antònia Molins; Miguel Feliz; Oscar Godino; Myriam Dávila; Juan José Acebes; Carles Arús
Journal:  MAGMA       Date:  2010-06-13       Impact factor: 2.310

3.  Glycerophosphodiester phosphodiesterase domain containing 5 (GDPD5) expression correlates with malignant choline phospholipid metabolite profiles in human breast cancer.

Authors:  Maria D Cao; Mailin Döpkens; Balaji Krishnamachary; Farhad Vesuna; Mayur M Gadiya; Per E Lønning; Zaver M Bhujwalla; Ingrid S Gribbestad; Kristine Glunde
Journal:  NMR Biomed       Date:  2012-01-26       Impact factor: 4.044

4.  Proton MR spectroscopy provides relevant prognostic information in high-grade astrocytomas.

Authors:  C Majós; J Bruna; M Julià-Sapé; M Cos; A Camins; M Gil; J J Acebes; C Aguilera; C Arús
Journal:  AJNR Am J Neuroradiol       Date:  2010-10-28       Impact factor: 3.825

5.  Influence of media selection on NMR based metabolic profiling of human cell lines.

Authors:  Tafadzwa Chihanga; Sarah M Hausmann; Shuisong Ni; Michael A Kennedy
Journal:  Metabolomics       Date:  2018-01-31       Impact factor: 4.290

6.  Identifying malignant transformations in recurrent low grade gliomas using high resolution magic angle spinning spectroscopy.

Authors:  Alexandra Constantin; Adam Elkhaled; Llewellyn Jalbert; Radhika Srinivasan; Soonmee Cha; Susan M Chang; Ruzena Bajcsy; Sarah J Nelson
Journal:  Artif Intell Med       Date:  2012-03-03       Impact factor: 5.326

Review 7.  Applications of high-resolution magic angle spinning MRS in biomedical studies II-Human diseases.

Authors:  Christopher Dietz; Felix Ehret; Francesco Palmas; Lindsey A Vandergrift; Yanni Jiang; Vanessa Schmitt; Vera Dufner; Piet Habbel; Johannes Nowak; Leo L Cheng
Journal:  NMR Biomed       Date:  2017-09-15       Impact factor: 4.044

Review 8.  MR Molecular Imaging of Brain Cancer Metabolism Using Hyperpolarized 13C Magnetic Resonance Spectroscopy.

Authors:  Chloé Najac; Sabrina M Ronen
Journal:  Top Magn Reson Imaging       Date:  2016-10

9.  Short-echo three-dimensional H-1 MR spectroscopic imaging of patients with glioma at 7 Tesla for characterization of differences in metabolite levels.

Authors:  Yan Li; Peder Larson; Albert P Chen; Janine M Lupo; Eugene Ozhinsky; Douglas Kelley; Susan M Chang; Sarah J Nelson
Journal:  J Magn Reson Imaging       Date:  2014-06-17       Impact factor: 4.813

10.  Ex-vivo HRMAS of adult brain tumours: metabolite quantification and assignment of tumour biomarkers.

Authors:  Alan J Wright; Greg A Fellows; John R Griffiths; M Wilson; B Anthony Bell; Franklyn A Howe
Journal:  Mol Cancer       Date:  2010-03-23       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.